Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiumi, N.
Right arrow Articles by Nakamura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiumi, N.
Right arrow Articles by Nakamura, M.
Clinical Cancer Research Vol. 9, 5616-5619, November 15, 2003
© 2003 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Use of 11p15 Mucins as Prognostic Factors in Small Adenocarcinoma of the Lung

Noboru Nishiumi1, Yoshiyuki Abe3, Yoshimasa Inoue2, Hiroyuki Hatanaka2, Ken-ichi Inada4, Hiroshi Kijima2, Hitoshi Yamazaki2, Masae Tatematsu4, Yoshito Ueyama2, Masayuki Iwasaki1, Hiroshi Inoue1 and Masato Nakamura2

1 Departments of General Thoracic Surgery and
2 Pathology, Tokai University School of Medicine, Isehara, Kanagawa;
3 Department of Respiratory Disease, National Kanagawa Hospital, Hadano, Kanagawa; and
4 Laboratory of Pathology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan

Purpose: Patients with small adenocarcinoma of the lung (SACL) generally have a good prognosis. However, some SACL cases show lymph node metastasis, with poor prognosis. The expression pattern of 11p15 mucins (clustered on the p15 arm of the chromosome 11) is known to change during carcinogenesis in lung cancer.

Experimental Design: We evaluated the expression of the 11p15 mucins (MUC2, MUC5AC, and MUC6) in 79 surgical specimens of SACL cases by immunohistochemical analysis. Lymph node metastasis was estimated by pathological staging.

Results: Six (7.6%) and 11 (13.9%) of the 79 SACL cases showed MUC2 and MUC6 expression, respectively. Three SACL cases showed both MUC2 and MUC6 expression, and a significant correlation was found between MUC2 and MUC6 expression (Fisher’s test, P = 0.033). Six (7.6%) SACL cases showed MUC5AC expression. Five of the 6 cases with MUC2 expression and 6 of the 11 cases with MUC6 expression were had lymph node metastasis. SACL cases with MUC2 or MUC6 expression showed a significantly higher incidence of nodal metastasis than those without expression (P < 0.001 and P = 0.006, {chi}2 test, respectively). There was no significant correlation between MUC5AC expression and nodal involvement in SACL, whereas three of the six cases with MUC5AC expression showed lymph node metastasis. The SACL cases with MUC2 expression had a significantly poorer prognosis than those without MUC2 expression (P = 0.011, log-rank test).

Conclusions: These results suggest that 11p15 mucins MUC2 and MUC6 are related to lymph node metastasis in SACL.




This article has been cited by other articles:


Home page
GlycobiologyHome page
T. Freire, R. Lo-Man, F. Piller, V. Piller, C. Leclerc, and S. Bay
Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination
Glycobiology, May 1, 2006; 16(5): 390 - 401.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.